Jeanne Chapron

708 total citations
23 papers, 535 citations indexed

About

Jeanne Chapron is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Jeanne Chapron has authored 23 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Jeanne Chapron's work include Cystic Fibrosis Research Advances (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Tracheal and airway disorders (4 papers). Jeanne Chapron is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Tracheal and airway disorders (4 papers). Jeanne Chapron collaborates with scholars based in France, Netherlands and United States. Jeanne Chapron's co-authors include Daniel Dusser, Pierre‐Régis Burgel, D. Hubert, Reem Kanaan, Isabelle Honoré, Pascaline Boudou‐Rouquette, François Goldwasser, Jérôme Alexandre, Étienne Audureau and Jacques F. Meis and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jeanne Chapron

22 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeanne Chapron France	13	249	152	131	123	91	23	535
Mutsuo Kuba Japan	14	191 0.8×	80 0.5×	181 1.4×	122 1.0×	16 0.2×	26	527
Alexander Geyer United States	11	251 1.0×	186 1.2×	86 0.7×	324 2.6×	62 0.7×	20	730
Masaharu Shinkai Japan	12	252 1.0×	30 0.2×	58 0.4×	87 0.7×	78 0.9×	37	392
Breno Bittencourt de Brito Brazil	13	106 0.4×	78 0.5×	82 0.6×	47 0.4×	17 0.2×	27	670
G Paone Italy	11	212 0.9×	82 0.5×	55 0.4×	112 0.9×	69 0.8×	24	427
Filipe Antônio França da Silva Brazil	13	104 0.4×	76 0.5×	81 0.6×	43 0.3×	16 0.2×	23	652
Lydia L. Benitez United States	9	49 0.2×	149 1.0×	57 0.4×	106 0.9×	26 0.3×	41	456
Shou-Chuan Shih Taiwan	13	125 0.5×	41 0.3×	52 0.4×	85 0.7×	38 0.4×	46	528
Aleksandra Safianowska Poland	14	159 0.6×	138 0.9×	36 0.3×	162 1.3×	26 0.3×	33	441
Maria Grazia Marazzi Italy	16	52 0.2×	78 0.5×	75 0.6×	336 2.7×	31 0.3×	29	801

Countries citing papers authored by Jeanne Chapron

Since Specialization

Citations

This map shows the geographic impact of Jeanne Chapron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeanne Chapron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeanne Chapron more than expected).

Fields of papers citing papers by Jeanne Chapron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeanne Chapron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeanne Chapron. The network helps show where Jeanne Chapron may publish in the future.

Co-authorship network of co-authors of Jeanne Chapron

This figure shows the co-authorship network connecting the top 25 collaborators of Jeanne Chapron. A scholar is included among the top collaborators of Jeanne Chapron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeanne Chapron. Jeanne Chapron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gounant, V., Nicolas Girard, Jacques Cadranel, et al.. (2024). Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma. Translational Lung Cancer Research. 13(9). 2212–2221. 1 indexed citations

Mansuet‐Lupo, Audrey, Hélène Blons, Elizabeth Fabre, et al.. (2024). Clinical and molecular characteristics associated with high PD-L1 expression in EGFR-mutated lung adenocarcinoma. PLoS ONE. 19(11). e0307161–e0307161. 1 indexed citations

Hirsch, Laure, Audrey Bellesœur, Pascaline Boudou‐Rouquette, et al.. (2019). The impact of body composition parameters on severe toxicity of nivolumab. European Journal of Cancer. 124. 170–177. 33 indexed citations

Jouinot, Anne, Jean-Philippe Durand, Pascaline Boudou‐Rouquette, et al.. (2019). Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients. Clinical Nutrition. 39(6). 1893–1899. 26 indexed citations

Labat, Laurence, Marie Allard, Pascaline Boudou‐Rouquette, et al.. (2018). Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients. Journal of Pharmaceutical and Biomedical Analysis. 158. 174–183. 54 indexed citations

Boudou‐Rouquette, Pascaline, Anne Jouinot, Olivier Huillard, et al.. (2017). Predictive and prognostic value of systemic inflammatory response biomarkers in patients receiving nivolumab for metastatic non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 35(15_suppl). 3055–3055. 4 indexed citations

Jouinot, Anne, Olivier Huillard, Pascaline Boudou‐Rouquette, et al.. (2017). Resting energy expenditure in the risk assessment of anticancer treatments. Clinical Nutrition. 37(2). 558–565. 30 indexed citations

Hubert, D., Pierre‐Régis Burgel, Isabelle Honoré, et al.. (2016). CFTR and/or pancreatitis susceptibility genes mutations as risk factors of pancreatitis in cystic fibrosis patients?. Pancreatology. 16(4). 515–522. 5 indexed citations

Bigot, Frédéric, Pascaline Boudou‐Rouquette, Jennifer Arrondeau, et al.. (2016). Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old. Investigational New Drugs. 35(2). 242–246. 20 indexed citations

10.

Gouya, H., Reem Kanaan, Isabelle Honoré, et al.. (2015). Renin-associated hypertension after bronchial artery embolization in cystic fibrosis. Journal of Cystic Fibrosis. 15(2). 213–215. 2 indexed citations

11.

Dupont, Christian, H. Gouya, D. Hubert, et al.. (2015). Complications of Peripherally Inserted Central Catheters in Adults with Cystic Fibrosis or Bronchiectasis. The Journal of Vascular Access. 16(3). 245–249. 12 indexed citations

12.

Morand, P, Clémence Martin, D. Hubert, et al.. (2015). Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. Journal of Cystic Fibrosis. 14(5). 594–599. 28 indexed citations

13.

Hubert, D., Pierre‐Régis Burgel, Emmanuelle Génin, et al.. (2015). DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. The Clinical Respiratory Journal. 10(6). 777–783. 10 indexed citations

14.

Deberne, M., Stanislas Ropert, Bertrand Billemont, et al.. (2014). Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?. BMC Cancer. 14(1). 416–416. 17 indexed citations

15.

Martin, Clémence, Jeanne Chapron, D. Hubert, et al.. (2013). Prognostic value of six minute walk test in cystic fibrosis adults. Respiratory Medicine. 107(12). 1881–1887. 45 indexed citations

16.

Mir, Olivier, Pascaline Boudou‐Rouquette, Julie Giroux, et al.. (2012). Pemetrexed, oxaliplatin and bevacizumab as first-line treatment in patients with stage IV non-small cell lung cancer. Lung Cancer. 77(1). 104–109. 12 indexed citations

17.

Chapron, Jeanne, Delphine Wermert, Françoise Le Pimpec‐Barthes, et al.. (2012). Bronchial rupture related to endobronchial stenting in relapsing polychondritis. European Respiratory Review. 21(126). 367–369. 11 indexed citations

18.

Laborde‐Castérot, Hervé, C. Donnay, Jeanne Chapron, et al.. (2011). Employment and work disability in adults with cystic fibrosis. Journal of Cystic Fibrosis. 11(2). 137–143. 30 indexed citations

19.

Mir, Olivier, Jérôme Alexandre, Romain Coriat, et al.. (2011). Safety of bevacizumab 7.5 mg/kg infusion over 10 minutes in NSCLC patients. Investigational New Drugs. 30(4). 1756–1760. 7 indexed citations

20.

Burgel, Pierre‐Régis, Marie-Thérèse Baixench, Étienne Audureau, et al.. (2011). High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole. Antimicrobial Agents and Chemotherapy. 56(2). 869–874. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact